BCWM
KRON

Bartlett & Co Wealth Management’s Kronos Bio KRON Stock Holding History

Bartlett & Co Wealth Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$117 – 1084
2021
Q1 		$117 Hold
4
– – ﹤0.01% 1097
2020
Q4 		$119 Buy
+4
New +$125 ﹤0.01% 1196

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bartlett & Co Wealth Management's KRON Position: Q2 2021 in Review

Bartlett & Co Wealth Management sold out of Kronos Bio (KRON) in Q2 2021, closing a stake of 4 shares — an estimated $117 sold.

Bartlett & Co Wealth Management first reported a position in KRON in Q4 2020 and held it in 2 quarters. The position peaked at $119 in Q4 2020. 77 funds tracked by Wall St. Rank hold KRON as of Q2 2021.

  • Bartlett & Co Wealth Management reported no remaining Kronos Bio position as of Q2 2021 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 4 Kronos Bio shares in Q2 2021, an estimated $117.
  • Bartlett & Co Wealth Management first reported a position in Kronos Bio in Q4 2020 and held it in 2 quarters.
  • Bartlett & Co Wealth Management's Kronos Bio position peaked at $119 in Q4 2020.
  • 77 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2021.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2021, filed 14 Feb 2024.